/akn/sg/act/sub_leg/2007/HPA-S333-2016

Health Products (Advertisement of Specified Health Products) Regulations 2016

The full official text, structured for quick navigation. Copy any provision or jump straight to a section.

Open source PDF
Type
Subsidiary Legislation
Status
In force
Enacted
2007
Sections
15

Quick answer

About this subsidiary legislation

Health Products (Advertisement of Specified Health Products) Regulations 2016 is Singapore Subsidiary Legislation, cited as Subsidiary Legislation HPA-S333-2016 2007, currently marked in force and first recorded in 2007.

Regulation 1

Citation and commencement

Open as pageSuggest a correction
Amended byS 109/2021 wef 01/03/2021

These Regulations are the Health Products (Advertisement of Specified Health Products) Regulations 2016 and come into operation on 1 November 2016.

Regulation 2

Definitions

Open as pageSuggest a correction
Amended byS 109/2021 wef 01/03/2021S 109/2021 wef 01/03/2021S 109/2021 wef 01/03/2021S 109/2021 wef 01/03/2021S 109/2021 wef 01/03/2021S 109/2021 wef 01/03/2021

In these Regulations, unless the context otherwise requires —“CTGT product” means a health product categorised as a cell, tissue or gene therapy product in the First Schedule to the Act;“enrolled nurse” means an individual who is enrolled as a nurse under the Nurses and Midwives Act (Cap. 209);“licensee”, in relation to a specified health product, means a holder of a manufacturer’s licence, an importer’s licence or a wholesaler’s licence for the specified health product;“non-public sector person” means a person other than —

(a)

a public authority established by a public Act for a public purpose; or

(b)

a person authorised by the Minister;“pharmacy-only medicine” means a therapeutic product registered under the classification of “pharmacy‑only medicine” in the Register of Health Products;“prescription-only medicine” means a specified health product registered under the classification of “prescription‑only medicine” in the Register of Health Products;“publish”, in relation to the advertisement of a specified health product, includes to distribute, show, display, exhibit, issue, disseminate or broadcast by any form of communication or in any manner;“qualified practitioner” means —

(a)

a registered medical practitioner under the Medical Registration Act (Cap. 174); or

(b)

a registered dentist under the Dental Registration Act (Cap. 76) whose name appears in the first division of the Register of Dentists maintained and kept under section 13(1)(a) of that Act;“registered midwife” means an individual who is registered as a midwife under the Nurses and Midwives Act;“registered nurse” means an individual who is registered as a nurse under the Nurses and Midwives Act;“registered pharmacist” means an individual who is registered as a pharmacist under the Pharmacists Registration Act (Cap. 230);“relevant health professionals” means individuals within any class of persons specified in the First Schedule;“sales promotion” means any advertisement of a specified health product in the form of a sales campaign (including door‑to‑door sales), exhibition, competition or any other activity meant to introduce, publicise or raise the profile or public awareness or visibility of the specified health product for the purpose of promoting the sale or use of the specified health product;“specified health product” means a health product specified in the Second Schedule;“therapeutic product” means a health product categorised as a therapeutic product in the First Schedule to the Act.

Definition

“CTGT product” means a health product categorised as a cell, tissue or gene therapy product in the First Schedule to the Act;

Amended byS 109/2021 wef 01/03/2021
Suggest a correction

Definition

“enrolled nurse” means an individual who is enrolled as a nurse under the Nurses and Midwives Act (Cap. 209);

Suggest a correction

Definition

“licensee”, in relation to a specified health product, means a holder of a manufacturer’s licence, an importer’s licence or a wholesaler’s licence for the specified health product;

Amended byS 109/2021 wef 01/03/2021
Suggest a correction

Definition

“non-public sector person” means a person other than —

(a)

a public authority established by a public Act for a public purpose; or

(b)

a person authorised by the Minister;

Suggest a correction

Definition

“pharmacy-only medicine” means a therapeutic product registered under the classification of “pharmacy‑only medicine” in the Register of Health Products;

Suggest a correction

Definition

“prescription-only medicine” means a specified health product registered under the classification of “prescription‑only medicine” in the Register of Health Products;

Amended byS 109/2021 wef 01/03/2021
Suggest a correction

Definition

“publish”, in relation to the advertisement of a specified health product, includes to distribute, show, display, exhibit, issue, disseminate or broadcast by any form of communication or in any manner;

Amended byS 109/2021 wef 01/03/2021
Suggest a correction

Definition

“qualified practitioner” means —

(a)

a registered medical practitioner under the Medical Registration Act (Cap. 174); or

(b)

a registered dentist under the Dental Registration Act (Cap. 76) whose name appears in the first division of the Register of Dentists maintained and kept under section 13(1)(a) of that Act;

Suggest a correction

Definition

“registered midwife” means an individual who is registered as a midwife under the Nurses and Midwives Act;

Suggest a correction

Definition

“registered nurse” means an individual who is registered as a nurse under the Nurses and Midwives Act;

Suggest a correction

Definition

“registered pharmacist” means an individual who is registered as a pharmacist under the Pharmacists Registration Act (Cap. 230);

Suggest a correction

Definition

“relevant health professionals” means individuals within any class of persons specified in the First Schedule;

Suggest a correction

Definition

“sales promotion” means any advertisement of a specified health product in the form of a sales campaign (including door‑to‑door sales), exhibition, competition or any other activity meant to introduce, publicise or raise the profile or public awareness or visibility of the specified health product for the purpose of promoting the sale or use of the specified health product;

Amended byS 109/2021 wef 01/03/2021
Suggest a correction

Definition

“specified health product” means a health product specified in the Second Schedule;

Amended byS 109/2021 wef 01/03/2021
Suggest a correction

Definition

“therapeutic product” means a health product categorised as a therapeutic product in the First Schedule to the Act.

Suggest a correction

Regulation 3

Requirements for advertisement of specified health products

Open as pageSuggest a correction
Amended byS 109/2021 wef 01/03/2021S 109/2021 wef 01/03/2021

For the purposes of section 21(1) of the Act, an advertisement of a specified health product must, subject to the modifications in regulation 11, 12, 13 or 14 —

(a)

comply with regulations 4, 5 and 6; and

(b)

be undertaken in accordance with the following regulations:

(i)

in the case of any specified health product — regulations 7, 9 and 10;

(ii)

in the case of a therapeutic product only — regulation 8.

Regulation 4

Matters to be excluded in advertising specified health products

Open as pageSuggest a correction
Amended byS 109/2021 wef 01/03/2021

An advertisement of a specified health product must not —

(a)

be likely to lead to a consumer of the specified health product self‑diagnosing or inappropriately treating any serious disease by himself or herself;

(b)

give the impression that advice from a registered pharmacist or qualified practitioner on the use of the specified health product is not necessary;

(c)

give the impression that a medical consultation or surgical operation is not necessary if the specified health product is used;

(d)

encourage, or be likely to encourage, inappropriate or excessive use of the specified health product;

(e)

mislead, or be likely to mislead, directly or by implication or through emphasis, contrast or omission, any person with regard to the quality or efficacy of the specified health product;

(f)

compare or contrast the specified health product with any other named specified health product or a brand thereof;

(g)

exploit the lack of knowledge of consumers, or contain any language or image that causes or is likely to cause fear, alarm or distress to the public in respect of any disease or condition;

(h)

claim or suggest that the specified health product is infallible, unfailing, magical or miraculous, or that the effect of taking the specified health product is certain, guaranteed or a sure cure;

(i)

claim or suggest that the specified health product is not accompanied by any side effects;

(j)

be likely to arouse unwarranted or unrealistic expectations of the effectiveness of the specified health product;

(k)

offer to fully or partially refund the purchase price of the specified health product, or guarantee or suggest that a full or partial refund of the purchase price of the specified health product will be given to any purchaser or user of the specified health product;

(l)

falsely claim or suggest that the use of the specified health product is promoted or endorsed by the Government or any public authority;

(m)

be directed, or contain any material that is directed, principally at any person below the age of 14 years; or

(n)

contain, or give the impression of, any endorsement or recommendation of the specified health product by —

(i)

any healthcare professional; or

(ii)

any person who, because of the person’s celebrity, social or professional status, is likely to encourage the use of the specified health product.

Regulation 5

Requirement for substantiation of assertions of uniqueness and prominence

Open as pageSuggest a correction
Amended byS 109/2021 wef 01/03/2021

Where an advertisement of a specified health product contains any statement, assertion, certification, award or feature of uniqueness or prominence differentiating the specified health product from any other competing or similar specified health product, the statement, assertion, certification, award or feature must be substantiated by facts or evidence.

Regulation 6

Restriction on promoting specified health products for specified diseases and conditions

Open as pageSuggest a correction
Amended byS 109/2021 wef 01/03/2021S 109/2021 wef 01/03/2021S 109/2021 wef 01/03/2021

Subregulation 1

Suggest a correction
Amended byS 109/2021 wef 01/03/2021

An advertisement by a non-public sector person of a specified health product must not expressly or implicitly claim, indicate or suggest that the specified health product —

(a)

will prevent, alleviate or cure any specified disease or condition;

(b)

will prevent or alleviate any sign or symptom clinically attributable to any specified disease or condition; or

(c)

has similar properties or characteristics to, or works as well as, a product that is commonly used for the purpose of treating any specified disease or condition.

Subregulation 2

Suggest a correction
Amended byS 109/2021 wef 01/03/2021

In this regulation, “specified disease or condition” means any disease or medical condition falling within any of the classes of diseases or medical conditions specified in the Third Schedule.

Regulation 7

Prohibition against advertisement of prescription‑only medicines

Open as pageSuggest a correction
Amended byS 109/2021 wef 01/03/2021

No advertisement of a specified health product by a non‑public sector person may relate to a prescription‑only medicine.

Regulation 8

Requirement for advertisement of pharmacy‑only medicines

Open as pageSuggest a correction

An advertisement of a pharmacy-only medicine by a non‑public sector person must prominently display an advisory or a warning statement required by the Authority to be displayed in connection with advertisements for that medicine.

Regulation 9

Requirements for advertisement of unregistered specified health products

Open as pageSuggest a correction
Amended byS 109/2021 wef 01/03/2021S 109/2021 wef 01/03/2021S 109/2021 wef 01/03/2021S 109/2021 wef 01/03/2021

Subregulation 1

Suggest a correction
Amended byS 109/2021 wef 01/03/2021

An advertisement of a specified health product that is not registered under the Act must —

(a)

be in the form of an article in a medical or scientific journal, review or publication;

(b)

be made in the course of providing or exchanging scientific or medical information at, and in accordance with the published programme or agenda of, a scientific conference or forum that is a private event; or

(c)

be made at a pharmaceutical trade fair, pharmaceutical trade exhibition, scientific conference or scientific forum that is a private event, for a specified health product that is approved, licensed or registered in at least one country outside Singapore, and contain a statement that the specified health product is not registered in Singapore.

Subregulation 2

Suggest a correction
Amended byS 109/2021 wef 01/03/2021

In addition, any advertisement of a specified health product that is not registered under the Act may contain a representation concerning the intended purpose or efficacy of the specified health product, provided that the representation has been verified by objective evidence.

Subregulation 3

Suggest a correction
Amended byS 109/2021 wef 01/03/2021

In paragraph (1), a reference to a private event is a reference to an event —

(a)

that is not open to attendance by the general public; and

(b)

at which the specified health product, which is the subject of the advertisement mentioned in paragraph (1), is not sold or offered for sale, and is not given out or offered as a sample.

Regulation 10

Sales promotions

Open as pageSuggest a correction
Amended byS 109/2021 wef 01/03/2021S 109/2021 wef 01/03/2021S 109/2021 wef 01/03/2021

Subregulation 1

Suggest a correction
Amended byS 109/2021 wef 01/03/2021

A person conducting any sales promotion involving a specified health product must not, in the course of that sales promotion, offer —

(a)

any prize as an inducement to purchase the specified health product;

(b)

together with the specified health product —

(i)

any other health product; or

(ii)

any medicinal product; or

(c)

any sample of the specified health product.

Subregulation 2

Suggest a correction
Amended byS 109/2021 wef 01/03/2021

A person must not distribute or give, or cause to be distributed or given, or assist in the distribution or giving of, any free sample of a specified health product to the public or any section of the public.

Subregulation 3

Suggest a correction
Amended byS 109/2021 wef 01/03/2021

To avoid doubt, paragraph (2) does not prohibit a qualified practitioner, or a person acting in accordance with the instructions of a qualified practitioner, from giving, or causing to be given, a sample of a specified health product to any patient of that qualified practitioner.

Subregulation 4

Suggest a correction

In this regulation, “medicinal product” has the same meaning as in the Medicines Act (Cap. 176).

Regulation 11

Professional or scientific information advertising

Open as pageSuggest a correction
Amended byS 109/2021 wef 01/03/2021

Regulations 4(f), 6(1) and 7, and in the case of a therapeutic product only, regulation 8, do not apply to an advertisement of a specified health product that —

(a)

is directed at, or is contained in any means for conveyance of information that is intended for publication to, one or more of the classes of relevant health professionals; or

(b)

is published only at a pharmaceutical trade fair, pharmaceutical trade exhibition, scientific conference or scientific forum that is not open to attendance by the general public.

Regulation 12

Reference and trade advertisements

Open as pageSuggest a correction
Amended byS 109/2021 wef 01/03/2021S 109/2021 wef 01/03/2021S 109/2021 wef 01/03/2021

Subregulation 1

Suggest a correction
Amended byS 109/2021 wef 01/03/2021

Regulations 6(1) and 7, and in the case of a therapeutic product only, regulation 8, do not apply to a reference advertisement or a trade advertisement.

Subregulation 2

Suggest a correction
Amended byS 109/2021 wef 01/03/2021S 109/2021 wef 01/03/2021

In this regulation —

Definition

“reference advertisement” means a form of advertisement of a specified health product —

(a)

containing a brief description of the specified health product, its intended purpose, and any contraindications or warnings relating to its use; and

(b)

appearing in a publication consisting mainly of such forms of advertisement where the publication is published by a person, who is not the manufacturer, supplier, retailer, importer or exporter of the specified health product, to one or more of the classes of relevant health professionals;

Amended byS 109/2021 wef 01/03/2021
Suggest a correction

Definition

“trade advertisement” means a form of advertisement of a specified health product which —

(a)

is published by means of a catalogue, price list or other document for the purpose of supplying the specified health product by wholesale; and

(b)

does not contain any recommendation relating to the use of the specified health product, other than as part of the name of the specified health product or as part of any heading or subheading indicating a therapeutic classification.

Amended byS 109/2021 wef 01/03/2021
Suggest a correction

Regulation 13

Informational statements

Open as pageSuggest a correction
Amended byS 109/2021 wef 01/03/2021S 109/2021 wef 01/03/2021

Subregulation 1

Suggest a correction
Amended byS 109/2021 wef 01/03/2021S 109/2021 wef 01/03/2021

Regulations 6(1) and 7, and in the case of a therapeutic product only, regulation 8, do not apply to an informational statement about a specified health product published —

(a)

on the corporate website of the registrant, manufacturer, importer, supplier or licensee of the specified health product;

(b)

as part of a product launch event that is not accessible to any member of the general public other than an invited guest; or

(c)

in the form of a press or media release,provided that —

(i)

any representation concerning the intended purpose and efficacy of the specified health product can be verified by objective evidence; and

(ii)

in the case of a corporate website, no discussion board or forum relating to the specified health product is held on the corporate website.

Subregulation 2

Suggest a correction

In this regulation, “corporate website” means an Internet website of a company that is accessible by the public and through which the public may obtain information about the company and its products.

Regulation 14

Sales promotions involving registered specified health products

Open as pageSuggest a correction
Amended byS 109/2021 wef 01/03/2021S 109/2021 wef 01/03/2021S 109/2021 wef 01/03/2021

Subregulation 1

Suggest a correction
Amended byS 109/2021 wef 01/03/2021

Regulation 10(1)(b) and (c) does not apply to any sales promotion involving a registered specified health product, if the specified health product —

(a)

is supplied to a qualified practitioner or a registered pharmacist; or

(b)

is supplied by wholesale by a person holding a valid wholesaler’s licence.

Subregulation 2

Suggest a correction
Amended byS 109/2021 wef 01/03/2021

Regulation 10(1)(c) and (2) does not apply to the distribution of samples of a registered specified health product to one or more of the classes of relevant health professionals at a pharmaceutical trade fair, pharmaceutical trade exhibition, scientific conference or scientific forum that is not open to attendance by the general public.

Regulation 15

Power of Authority to require copies of advertisements

Open as pageSuggest a correction
Amended byS 109/2021 wef 01/03/2021

Subregulation 1

Suggest a correction
Amended byS 109/2021 wef 01/03/2021

The Authority may require, by written notice, any person who advertises, causes to be advertised, or is about to advertise or cause to be advertised, a specified health product to furnish to the Authority, within the time specified in the notice, such number of copies of any document or material containing the advertisement as the Authority may specify in the notice.

Subregulation 2

Suggest a correction

Any person who fails to comply with a written notice under paragraph (1) shall be guilty of an offence and shall be liable on conviction to a fine not exceeding $10,000 or to imprisonment for a term not exceeding 6 months or to both.

Common questions

What is Health Products (Advertisement of Specified Health Products) Regulations 2016?
Health Products (Advertisement of Specified Health Products) Regulations 2016 is Singapore Subsidiary Legislation, cited as Subsidiary Legislation HPA-S333-2016 2007, currently marked in force and first recorded in 2007.
Is Health Products (Advertisement of Specified Health Products) Regulations 2016 still in force?
Yes — Health Products (Advertisement of Specified Health Products) Regulations 2016 is currently in force.
When did Health Products (Advertisement of Specified Health Products) Regulations 2016 take effect?
Health Products (Advertisement of Specified Health Products) Regulations 2016 was first recorded in 2007.
How many regulations does Health Products (Advertisement of Specified Health Products) Regulations 2016 have?
Health Products (Advertisement of Specified Health Products) Regulations 2016 contains 15 regulations.
Where can I read the official version of Health Products (Advertisement of Specified Health Products) Regulations 2016?
The official text of Health Products (Advertisement of Specified Health Products) Regulations 2016 is published at sso.agc.gov.sg.